3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Genitourinary
2
Conditions
Colorectal Neoplasms
4
Carcinoma, Renal Cell
3
Sarcoma
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Castration-resistant Prostate Cancer
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Osteosarcoma
1
Lymphatic Metastasis
1
Ependymoma
1
Colonic Neoplasms
1
Clear-cell metastatic renal cell carcinoma
1
Breast Neoplasms
1
Bone Neoplasms
1
Adenocarcinoma
1
Interventions
Docetaxel
171
Radiotherapy
144
Magnetic Resonance Spectroscopy
142
Leuprolide
112
Prednisone
108
enzalutamide
102
Radiosurgery
101
Abiraterone Acetate
94
Androgen Antagonists
91
Goserelin
83
bicalutamide
81
gallium 68 PSMA-11
70
Surveys and Questionnaires
63
apalutamide
57
Specimen Handling
56
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
55
Radiation
47
Gonadotropin-Releasing Hormone
45
Standard of Care
44
Biopsy
44
Brachytherapy
42
Radiotherapy, Intensity-Modulated
40
Blood Specimen Collection
40
darolutamide
39
abiraterone
39
cabazitaxel
35
Exercise
35
Carboplatin
33
Pluvicto
32
Triptorelin Pamoate
31
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER
×
Prostatic Neoplasms
×
Metastasectomy
×
Clear all
NCT03796767
2026-01-28
SOAR
University of Utah
Phase 2
Active not recruiting
20 enrolled
26 charts
NCT05352178
2024-07-03
SPARKLE
Universitaire Ziekenhuizen KU Leuven
Phase 3
Recruiting
873 enrolled